Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia.
Anether
Gabriele
G
Marschitz
Ingrid
I
Tinhofer
Inge
I
Greil
Richard
R
D017209:Apoptosis; D019013:CD40 Antigens / Q000276:immunology; D023201:CD40 Ligand / Q000235:genetics / Q000502:physiology*; D053222:Fas Ligand Protein; D015316:Genetic Therapy; D006801:Humans; D019409:Interleukin-15 / Q000235:genetics / Q000502:physiology*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics / Q000628:therapy*; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000502:physiology; D014411:Neoplastic Stem Cells / Q000637:transplantation; D015398:Signal Transduction; D016176:T-Lymphocyte Subsets / Q000276:immunology; D018417:Th1 Cells / Q000276:immunology; D019014:fas Receptor / Q000502:physiology
D019013:CD40 Antigens; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D019409:Interleukin-15; D008562:Membrane Glycoproteins; D019014:fas Receptor; D023201:CD40 Ligand